Tag: PORTLAND, Ore.
The City of Portland is anxious to bring additional cellular coverage to their citizens – RFP awarded to XG Communities
PORTLAND, Ore., April 2, 2018 (SEND2PRESS NEWSWIRE) -- XG Communities, a premier provider of wireless marketing plans and engineering services for cities and municipalities across the United States, has been awarded an exclusive wireless marketing agreement with the City of Portland.
Paragon BioTeck Calls Emerging Leaders to Apply for 2018 Ophthalmology Scholarship
PORTLAND, Ore., Oct. 2, 2017 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately-held pharmaceutical and medical device company, today announced the call for the next Koch Kellan Scholar. The annual Koch Kellan Scholarship honors one outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and a clinical, teaching, or research career in ophthalmology. A Paragon Gives initiative, the scholarship reinforces the fundamental mission of Paragon BioTeck to drive innovations to address unmet and underserved medical needs.
Xinxin Zhang Named 2017 Koch Kellan Scholar
PORTLAND, Ore., April 12, 2017 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., an ophthalmic pharmaceutical and device company, announced today that Xinxin Zhang has been named its 2017 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology.
Hasenin Al-khersan Named 2016 Koch Kellan Scholar
PORTLAND, Ore., April 18, 2016 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., announced today that Hasenin Al-khersan has been named its 2016 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology.
Paragon BioTeck Receives EN ISO 13485:2012 Certification
PORTLAND, Ore., March 29, 2016 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today that it has received EN ISO 13485:2012 certification, signifying the company's successful implementation of an effective quality management system.
Paragon BioTeck to Attend 34th Annual J.P. Morgan Healthcare Conference
PORTLAND, Ore., Jan. 7, 2016 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, will sponsor a special reception during the J.P. Morgan 2016 Healthcare Conference, being held in San Francisco, January 11-14. The conference, which is now in its 34th year, is an invitation-only event intended to create an environment of collaboration by bringing together stakeholders in the corporate, investor and financial sectors to learn about and explore market and sector trends.
Paragon BioTeck to Exhibit at American Academy of Ophthalmology Annual Meeting in Chicago
PORTLAND, Ore., Oct. 15, 2014 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, will be exhibiting at the American Academy of Ophthalmology (Booth #4550) in Chicago, Ill., on October 18 - 21.
